In vivo, RGD-Lip-SHK had the strongest targeted anti-melanoma effect by αVβ3-mediated endocytosis with a long circulation time and inhibited tumor growth in B16F10 tumor-bearing mice compared to other groups. Here, SHPK is linked to melanoma.